Search

How primary neuronal cell cultures are unraveling the role of amyloid β oligomers in Alzheimer’s disease.

Sitting Down With… Mike Clayman, CEO of Flexion Therapeutics, Inc., Burlington, Massachusetts, USA.

Sitting Down with Michael Tanner, Research Fellow in the School of Engineering and Physical Sciences at Heriot Watt University, Edinburgh, UK.

RNA Inhibitors - an exciting avenue for drug development? We collate the findings from the Innovation that Matters series, hosted by WuXi Xpress...

Vaccines are biological preparations that contain agents resembling disease causing microorganisms, and can improve immunity against specific diseases

Researchers fine-tune 3D printing technology to create better biomimetic corneas – and predict a “breakthrough” in global transplantation practice.

A new study uses machine learning to perform meta-analysis of eight metagenomic studies linking gut microbial signatures with colorectal cancer.

Could modulation of fibroblast growth factor 21 translate into a new treatment for non-alcoholic fatty liver disease?

To truly understand the intricacies of pathogenic bacteria, we need to combine “pure” and translational research.

Combining metabolomics and DNA sequencing could be the key to discovering new inborn errors of metabolism in children.